Cited by 662Estrogen and related hormone effectsMetal-Catalyzed Oxygenation MechanismsEnzyme Structure and Function

The DOI matches its Crossref record; 34 of the 35 references it cites were found in a registry or an index.

Structural basis for androgen specificity and oestrogen synthesis in human aromatase

Open access

Ghosh, Debashis, Griswold, Jennifer, Erman, Mary, Pangborn, Walter·2009·Nature

DOI 10.1038/nature07614PMC PMC2820300

Open this paper in CoChat — free account

Abstract

Aromatase cytochrome P450 is the only enzyme in vertebrates known to catalyse the biosynthesis of all oestrogens from androgens. Aromatase inhibitors therefore constitute a frontline therapy for oestrogen-dependent breast cancer. In a three-step process, each step requiring 1 mol of O(2), 1 mol of NADPH, and coupling with its redox partner cytochrome P450 reductase, aromatase converts androstenedione, testosterone and 16alpha-hydroxytestosterone to oestrone, 17beta-oestradiol and 17beta,16alpha-oestriol, respectively. The first two steps are C19-methyl hydroxylation steps, and the third involves the aromatization of the steroid A-ring, unique to aromatase. Whereas most P450s are not highly substrate selective, it is the hallmark androgenic specificity that sets aromatase apart. The structure of this enzyme of the endoplasmic reticulum membrane has remained unknown for decades, hindering elucidation of the biochemical mechanism. Here we present the crystal structure of human placental aromatase, the only natural mammalian, full-length P450 and P450 in hormone biosynthetic pathways to be crystallized so far. Unlike the active sites of many microsomal P450s that metabolize drugs and xenobiotics, aromatase has an androgen-specific cleft that binds the androstenedione molecule snugly. Hydrophobic and polar residues exquisitely complement the steroid backbone. The locations of catalytically important residues shed light on the reaction mechanism. The relative juxtaposition of the hydrophobic amino-terminal region and the opening to the catalytic cleft shows why membrane anchoring is necessary for the lipophilic substrates to gain access to the active site. The molecular basis for the enzyme's androgenic specificity and unique catalytic mechanism can be used for developing next-generation aromatase inhibitors.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/nature07614

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

UCSF Chimera—A visualization system for exploratory research and analysis
Pettersen, E. F., Goddard, T. D., Huang, C. C., Couch, G. S., Greenblatt, D. M., Meng, E. C., & Ferrin, T. E. (2004) · Journal of Computational Chemistry · doi:10.1002/jcc.20084 · Cited by 45,882
Coot : model-building tools for molecular graphics
Emsley, P., & Cowtan, K. (2004) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444904019158 · Cited by 30,571
The CCP4 suite: programs for protein crystallography
Number Collaborative Computational Project (1994) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444994003112 · Cited by 17,317
Refinement of Macromolecular Structures by the Maximum-Likelihood Method
Murshudov, G. N., Vagin, A. A., & Dodson, E. J. (1997) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444996012255 · Cited by 14,796
Aromatase Cytochrome P450, The Enzyme Responsible for Estrogen Biosynthesis*
SIMPSON, E. R., Mahendroo, M., Means, G., Kilgore, M. W., Hinshelwood, M. M., Graham-Lorence, S. E., Amarneh, B., Ito, Y., Fisher, C. R., Michael, M. D., et al. (1994) · Endocrine Reviews · doi:10.1210/edrv-15-3-342 · Cited by 1,542
Crystal Structures of Human Cytochrome P450 3A4 Bound to Metyrapone and Progesterone
Williams, P. A., Cosme, J., Matak‐Vinković, D., Ward, A., Angove, H. C., Day, P. J., Vonrhein, C., Tickle, I. J., & Jhoti, H. (2004) · Science · doi:10.1126/science.1099736 · Cited by 807
Utilization of Oxygen and Reduced Nicotinamide Adenine Dinucleotide Phosphate by Human Placental Microsomes during Aromatization of Androstenedione
Thompson, E. A., & Siiteri, P. K. (1974) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)79735-8 · Cited by 698
Crystal structure of cytochrome P450 14α-sterol demethylase (CYP51) from Mycobacterium tuberculosis in complex with azole inhibitors
Podust, L. M., Poulos, T. L., & Waterman, M. R. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.061562898 · Cited by 542
Crystal Structure of Human Cytochrome P450 2D6
Rowland, P., Blaney, F. E., Smyth, M. G., Jones, J. J., Leydon, V. R., Oxbrow, A., Lewis, C. J., Tennant, M., Modi, S. P., Eggleston, D. S., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m511232200 · Cited by 442
The ins and outs of cytochrome P450s
Cojocaru, V., Winn, P. J., & Wade, R. C. (2006) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2006.07.005 · Cited by 364

Flagged first, then by citations

Show all 35 references

1 of the 35 references couldn’t be matched to a known paper.

Research works printed but not linked: 2

Sato, R. & Omura, T. Cytochrome P-450 (Kodansha/Academic, 1978)
Otninowski, Z. & Minor, W. HKL Manual (Yale University, 1995)

Sorted by citations

Items 201–300 of 662

Synthesis and Structure–Activity Relationship Studies of Derivatives of the Dual Aromatase–Sulfatase Inhibitor 4‐{[(4‐Cyanophenyl)(4H‐1,2,4‐triazol‐4‐yl)amino]methyl}phenyl sulfamate
Woo, L. W. L., Wood, P. M., Bubert, C., THOMAS, M. P., Purohit, A., & Potter, B. V. L. (2013) · ChemMedChem · doi:10.1002/cmdc.201300015 · Cited by 32
Cannabidiol (CBD) but not tetrahydrocannabinol (THC) dysregulate in vitro decidualization of human endometrial stromal cells by disruption of estrogen signaling
Almada, M., Amaral, C., de Oliveira, A. L. N., Fernandes, P. A., Ramos, M. J., Fonseca, B. M., Correia‐da‐Silva, G., & Teixeira, N. A. A. (2020) · Reproductive Toxicology · doi:10.1016/j.reprotox.2020.01.003 · Cited by 32
Optimization of the aromatase inhibitory activities of pyridylthiazole analogues of resveratrol
Mayhoub, A. S., Marler, L., Kondratyuk, T. P., Park, E., Pezzuto, J. M., & Cushman, M. (2012) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2012.01.047 · Cited by 31
Aromatase induction in tamoxifen-resistant breast cancer: Role of phosphoinositide 3-kinase-dependent CREB activation
Phương, N. T. T., Lim, S., Kim, Y. M., & Kang, K. W. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.05.003 · Cited by 31
The use of isomeric testosterone dimers to explore allosteric effects in substrate binding to cytochrome P450 CYP3A4
Denisov, I. G., Mak, P. J., Grinkova, Y. V., Bastien, D., Bérubé, G., Sligar, S. G., & Kincaid, J. R. (2015) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2015.12.019 · Cited by 31
Sulfonanilide Derivatives in Identifying Novel Aromatase Inhibitors by Applying Docking, Virtual Screening, and MD Simulations Studies
Rampogu, S. D., Son, M., Park, C., Kim, H.-H., Suh, J.-K., & Lee, K. W. (2017) · BioMed Research International · doi:10.1155/2017/2105610 · Cited by 30
Aromatase inhibition by 2-methyl indole hydrazone derivatives evaluated via molecular docking and in vitro activity studies
Ozcan, S., İnce, E., Akdemir, A., Ceylan, Ö. Ö., Süzen, S., & Gürer-Orhan, H. (2018) · Xenobiotica · doi:10.1080/00498254.2018.1482029 · Cited by 30
Synthesis of Triphenylethylene Bisphenols as Aromatase Inhibitors That Also Modulate Estrogen Receptors
Lv, W., Liu, J., Skaar, T. C., O’Neill, E., Yu, G., Flockhart, D. A., & Cushman, M. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01677 · Cited by 30
Modeling of human P450 oxidoreductase structure by in silico mutagenesis and MD simulation
Flück, C. E., Mullis, P. E., & Pandey, A. V. (2009) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2009.09.001 · Cited by 30
Effect of Essential Oil Components on the Activity of Steroidogenic Cytochrome P450
Sharma, K., Lanzilotto, A., Yakubu, J., Therkelsen, S., Voegel, C. D., du Toit, T., Jørgensen, F. S., & Pandey, A. V. (2024) · Biomolecules · doi:10.3390/biom14020203 · Cited by 29
TRPA1 Mediates Aromatase Inhibitor–Evoked Pain by the Aromatase Substrate Androstenedione
Logu, F. D., Tonello, R., Materazzi, S., Nassini, R., Fusi, C., Coppi, E., Puma, S. L., Marone, I. M., Sadofsky, L. R., Morice, A. H., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-1492 · Cited by 29
Acyl-Carbon Bond Cleaving Cytochrome P450 Enzymes: CYP17A1, CYP19A1 and CYP51A1
Akhtar, M., & Wright, J. N. (2015) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-16009-2_4 · Cited by 28
Antihormonal potential of selected D-homo and D-seco estratriene derivatives
Jovanović-Šanta, S., Petri, E. T., Klisurić, O. R., Szécsi, M., Kovačević, R., & Petrović, J. (2014) · Steroids · doi:10.1016/j.steroids.2014.08.026 · Cited by 29
Insights on the interaction mechanism of exemestane to three digestive enzymes by multi-spectroscopy and molecular docking
Huang, Y., Zhao, G., Jin, Z., Gao, Y., & Wang, H. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2021.07.079 · Cited by 28
Cytochrome P450 monooxygenase systems: Diversity and plasticity for adaptive stress response
Mokhosoev, I. M., Astakhov, D. V., Terentiev, A. A., & Moldogazieva, N. T. (2024) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2024.09.003 · Cited by 31
Epitope Characterization of an Aromatase Monoclonal Antibody Suitable for the Assessment of Intratumoral Aromatase Activity
Hong, Y., Li, H., Ye, J., Miki, Y., Yuan, Y.-C., Sasano, H., Evans, D. B., & Chen, S. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008050 · Cited by 28
Impact of R264C and R264H polymorphisms in human aromatase function
Baravalle, R., Nardo, G. D., Bandino, A., Barone, I., Catalano, S., Andò, S., & Gilardi, G. (2016) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2016.09.022 · Cited by 28
Synthesis, structure-activity relationships and molecular docking studies of phenyldiazenyl sulfonamides as aromatase inhibitors
Giampietro, L., Gallorini, M., Gambacorta, N., Ammazzalorso, A., Filippis, B. D., Valle, A. D., Fantacuzzi, M., Maccallini, C., Mollica, A., Cataldi, A., et al. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113737 · Cited by 28
Enhanced inhibition of human and rat aromatase activity by benzene ring substitutions in bisphenol A: QSAR structure-activity relationship and in silico docking analysis
Zheng, J., Chen, S., Han, L., Xia, M., Wang, S., Li, X., Li, H., Wang, Y., Ge, R., & Liu, Y. (2023) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2023.133252 · Cited by 28
Oestrogens and androgen receptors in oral squamous cell carcinoma
Marocchio, L. S., Giudice, F. S., Côrrea, L., Júnior, D. D. S. P., & de Sousa, S. O. M. (2013) · Acta Odontologica Scandinavica · doi:10.3109/00016357.2013.775335 · Cited by 28
Joint Use of Bonding Evolution Theory and QM/MM Hybrid Method for Understanding the Hydrogen Abstraction Mechanism via Cytochrome P450 Aromatase
Viciano, I., González‐Navarrete, P., Andrés, J., & Martı́, S. (2015) · Journal of Chemical Theory and Computation · doi:10.1021/ct501030q · Cited by 28
Design and Synthesis of New pyrazole Hybrids Linked to Oxime and Nitrate Moieties as COX-2, EGFRL858R/T790M Inhibitors and Nitric Oxide Donors with dual Anti-inflammatory/Anti-proliferative Activities
Fadaly, W. A. A., Nemr, M. T. M., El-Hameed, A. M. A., Mohamed, F. E. A., & Zidan, T. H. (2025) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2025.108563 · Cited by 32
Molecular Modeling on Inhibitor Complexes and Active-Site Dynamics of Cytochrome P450 C17, a Target for Prostate Cancer Therapy
Haider, S. M., Patel, J. S., Poojari, C., & Neidle, S. (2010) · Journal of Molecular Biology · doi:10.1016/j.jmb.2010.05.069 · Cited by 27
The Vascular Endothelial Growth Factor Receptor Inhibitor PTK787/ZK222584 Inhibits Aromatase
Banerjee, S. N., Zvelebil, M., Furet, P., Mueller‐Vieira, U., Evans, D. B., Dowsett, M., & Martin, L. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4711 · Cited by 27
Exploring the Therapeutic Ability of Fenugreek against Type 2 Diabetes and Breast Cancer Employing Molecular Docking and Molecular Dynamics Simulations
Rampogu, S. D., Saravanan, P., Lemuel, M. R., & Lee, K. W. (2018) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2018/1943203 · Cited by 27
Design, synthesis and biochemical studies of new 7α-allylandrostanes as aromatase inhibitors
Varela, C. L., Amaral, C., Correia‐da‐Silva, G., Carvalho, R. A., Teixeira, N. A. A., Costa, S. C., Roleira, F. M. F., & da Silva, E. J. T. (2013) · Steroids · doi:10.1016/j.steroids.2013.02.016 · Cited by 26
Synthesis of New Pyrimidine‐Triazole Derivatives and Investigation of Their Anticancer Activities
Osmani̇ye, D., Hıdır, A., Sağlık, B. N., Levent, S., Özkay, Y., & Kaplancıklı, Z. A. (2022) · Chemistry & Biodiversity · doi:10.1002/cbdv.202200216 · Cited by 26
New imidazole derivatives as aromatase inhibitor: Design, synthesis, biological activity, molecular docking, and computational ADME-Tox studies
Çetiner, G., Çevik, U. A., Çeli̇k, İ., Bostancı, H. E., Özkay, Y., & Kaplancıklı, Z. A. (2023) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2023.134920 · Cited by 26
Lignin-derived oak phenolics: a theoretical examination of additional potential health benefits of red wine
Setzer, W. N. (2010) · Journal of Molecular Modeling · doi:10.1007/s00894-010-0893-3 · Cited by 26
Comprehensive and Automated Linear Interaction Energy Based Binding-Affinity Prediction for Multifarious Cytochrome P450 Aromatase Inhibitors
van Dijk, M., ter Laak, A., Wichard, J., Capoferri, L., Vermeulen, N. P. E., & Geerke, D. P. (2017) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.7b00222 · Cited by 26
Phosphorylation of human placental aromatase CYP19A1
Ghosh, D., Egbuta, C., Kanyo, J. E., & Lam, T. T. (2019) · Biochemical Journal · doi:10.1042/bcj20190633 · Cited by 27
Self-citation
Exploiting the Chromone Scaffold for the Development of Inhibitors of Corticosteroid Biosynthesis
Gobbi, S., Hu, Q., Zimmer, C., Engel, M., Belluti, F., Rampa, A., Hartmann, R. W., & Bisi, A. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01609 · Cited by 26
Investigation of fluorinated and bifunctionalized 3-phenylchroman-4-one (isoflavanone) aromatase inhibitors
Amato, E., Bankemper, T., Kidney, R., Do, T., Oñate, A., Thowfeik, F. S., Merino, E. J., Paula, S., & Ma, L. (2013) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2013.11.045 · Cited by 25
Recent advances in computational design of potent aromatase inhibitors: open-eye on endocrine-resistant breast cancers
Spinello, A., Ritacco, I., & Magistrato, A. (2019) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2019.1646245 · Cited by 25
Synthesis, characterization, biological evaluation and in silico studies of novel 1,3,4-thiadiazole derivatives as aromatase inhibitors
Demiraran, S., Osmani̇ye, D., Özkay, Y., Kaplancıklı, Z. A., Koçyiğit‐Kaymakçıoğlu, B., & Tok, F. (2023) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2023.136903 · Cited by 25
Bicyclic Derivatives of the Potent Dual Aromatase–Steroid Sulfatase Inhibitor 2‐Bromo‐4‐{[(4‐cyanophenyl)(4H‐1,2,4‐triazol‐4‐yl)amino]methyl}phenylsulfamate: Synthesis, SAR, Crystal Structure, and in vitro and in vivo Activities
Wood, P. M., Woo, L. W. L., Labrosse, J., THOMAS, M. P., Mahon, M. F., Chander, S. K., Purohit, A., Reed, M. J., & Potter, B. V. L. (2010) · ChemMedChem · doi:10.1002/cmdc.201000203 · Cited by 25
Divergent mechanisms of iron-containing enzymes for hydrocarbon biosynthesis
Wise, C. E., Grant, J. L., Amaya, J. A., Ratigan, S. C., Hsieh, C. H., Manley, O. M., & Makris, T. M. (2016) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-016-1425-0 · Cited by 25
Post-Translational Regulation of CYP450s Metabolism As Revealed by All-Atoms Simulations of the Aromatase Enzyme
Ritacco, I., Spinello, A., Ippoliti, E., & Magistrato, A. (2019) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.9b00157 · Cited by 25
Evaluating flavonoids as potential aromatase inhibitors for breast cancer treatment: In vitro studies and in silico predictions
Seo, J. I., Yu, J. S., Zhang, Y., & Yoo, H. H. (2024) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2024.110927 · Cited by 24
Effective anti-aromatase therapy to battle against estrogen-mediated breast cancer: Comparative SAR/QSAR assessment on steroidal aromatase inhibitors
Adhikari, N., Baidya, S. K., & Jha, T. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112845 · Cited by 24
Sex-specific lung diseases: effect of oestrogen on cultured cells and in animal models
Shim, B., Pacheco–Rodriguez, G., Kato, J., Darling, T. N., Vaughan, M. M., & Moss, J. (2013) · European Respiratory Review · doi:10.1183/09059180.00002813 · Cited by 24
Design, synthesis, in vitro and in silico studies of some novel triazoles as anticancer agents for breast cancer
Osmani̇ye, D., Sağlık, B. N., Levent, S., Ilgın, S., Özkay, Y., & Kaplancıklı, Z. A. (2021) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2021.131198 · Cited by 23
Chemicals of environmental concern as inhibitors of human placental 3β-hydroxysteroid dehydrogenase 1 and aromatase: Screening and docking analysis
Tang, L., Shi, L., Tang, Y., Ying, Y., Dong, Y., Li, H., & Ge, R. (2022) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2022.110243 · Cited by 23
Structures and functions of human placental aromatase and steroid sulfatase, two key enzymes in estrogen biosynthesis
Ghosh, D. (2023) · Steroids · doi:10.1016/j.steroids.2023.109249 · Cited by 23
Self-citation
Molecular Recognition of Steroid Hormones in the Solid State: Stark Differences in Cocrystallization of β-Estradiol and Estrone
Ardila‐Fierro, K. J., André, V., Tan, D., Duarte, M. T., Lancaster, R. W., Karamertzanis, P. G., & Friščić, T. (2015) · Crystal Growth & Design · doi:10.1021/cg501865h · Cited by 23
Pyridine‐substituted thiazolylphenol derivatives: Synthesis, modeling studies, aromatase inhibition, and antiproliferative activity evaluation
Ertaş, M., Şahin, Z., Berk, B., Yurttaş, L., Biltekin, S. N., & Demirayak, Ş. (2018) · Archiv der Pharmazie · doi:10.1002/ardp.201700272 · Cited by 23
Food components and environmental chemicals of inhibiting human placental aromatase
Wang, Y., Pan, P., Li, X., Zhu, Q., Huang, T., & Ge, R. (2019) · Food and Chemical Toxicology · doi:10.1016/j.fct.2019.03.043 · Cited by 22
Design of new molecules against cervical cancer using DFT, theoretical spectroscopy, 2D/3D-QSAR, molecular docking, pharmacophore and ADMET investigations
Rhabori, S. E., Aissouq, A. E., Daouı, O., Elkhattabi, S., Chtita, S., & Khalil, F. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e24551 · Cited by 22
Insight into the binding interactions of CYP450 aromatase inhibitors with their target enzyme: a combined molecular docking and molecular dynamics study
Galeazzi, R., & Massaccesi, L. (2011) · Journal of Molecular Modeling · doi:10.1007/s00894-011-1144-y · Cited by 21
Higher order organization of human placental aromatase
Ghosh, D., Jiang, W., Lo, J., & Egbuta, C. (2011) · Steroids · doi:10.1016/j.steroids.2011.02.030 · Cited by 22
Self-citation
Synthesis, investigation of biological effects and in silico studies of new benzimidazole derivatives as aromatase inhibitors
Sağlık, B. N., Şen, A. M., Evren, A. E., Çevik, U. A., Osmani̇ye, D., Çavuşoğlu, B. K., Levent, S., Karaduman, A. B., Özkay, Y., & Kaplancıklı, Z. A. (2020) · Zeitschrift für Naturforschung C · doi:10.1515/znc-2020-0104 · Cited by 22
Developing multitarget coumarin based anti-breast cancer agents: synthesis and molecular modeling study
Takla, F. N., Bayoumi, W. A., El-Messery, S. M., & Nasr, M. N. A. (2023) · Scientific Reports · doi:10.1038/s41598-023-40232-3 · Cited by 21
Convenient method for the functionalization of the 4- and 6-positions of the androgen skeleton
Morton, D., Dick, A. R., Ghosh, D., & Davies, H. M. L. (2012) · Chemical Communications · doi:10.1039/c2cc31973j · Cited by 21
Self-citation
3D-QSAR study of steroidal and azaheterocyclic human aromatase inhibitors using quantitative profile of protein–ligand interactions
Lee, S., & Barron, M. G. (2018) · Journal of Cheminformatics · doi:10.1186/s13321-017-0253-8 · Cited by 21
Targeting Orthosteric and Allosteric Pockets of Aromatase via Dual-Mode Novel Azole Inhibitors
Caciolla, J., Spinello, A., Martini, S., Bisi, A., Zaffaroni, N., Gobbi, S., & Magistrato, A. (2020) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.9b00591 · Cited by 21
Targeting allosteric sites of human aromatase: a comprehensive in-silico and in-vitro workflow to find potential plant-based anti-breast cancer therapeutics
Alhadrami, H. A., Sayed, A. M., Melebari, S., Khogeer, A., Abdulaal, W. H., Al‐Fageeh, M. B., Algahtani, M., & Rateb, M. E. (2021) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2021.1937145 · Cited by 21
Novel imidazole derivatives as potential aromatase and monoamine oxidase-B inhibitors against breast cancer
Osmani̇ye, D., Levent, S., Sağlık, B. N., Karaduman, A. B., Özkay, Y., & Kaplancıklı, Z. A. (2022) · New Journal of Chemistry · doi:10.1039/d2nj00424k · Cited by 21
In silico ADMET analysis of the A-, B- and D-modified androstane derivatives with potential anticancer effects
Šestić, T. L., Ajduković, J. J., Marinović, M., Petri, E. T., & Savić, M. P. (2022) · Steroids · doi:10.1016/j.steroids.2022.109147 · Cited by 21
Synthesis of some novel androstanes as potential aromatase inhibitors
Yadav, M. R., Sabale, P., Giridhar, R., Zimmer, C., Haupenthal, J., & Hartmann, R. W. (2011) · Steroids · doi:10.1016/j.steroids.2010.12.013 · Cited by 21
Correlated Evolution of Androgen Receptor and Aromatase Revisited
Reitzel, A. M., & Tarrant, A. M. (2010) · Molecular Biology and Evolution · doi:10.1093/molbev/msq129 · Cited by 21
The Clinical Application of Ozonetherapy
Bocci, V. A. (2010) · Springer eBooks · doi:10.1007/978-90-481-9234-2_9 · Cited by 24
Aromatase deficiency: a novel compound heterozygous mutation identified in a Chinese girl with severe phenotype and obvious maternal virilization
Zhu, W., Cheng, T., Zhu, H., Han, B., Fan, M., Gu, T., Zhao, S., Liu, Y., Cheng, K., Song, H., et al. (2016) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2016.05.025 · Cited by 20
Synthesis and Anticancer Activity of Thiadiazole Containing Thiourea, Benzothiazole and Imidazo[2,1-b][1,3,4]thiadiazole Scaffolds
Avvaru, S. P., Noolvi, M. N., More, U. A., Chakraborty, S., Dash, A. K., Aminabhavi, T. M., Narayan, K. P., & Sutariya, V. (2020) · Medicinal Chemistry · doi:10.2174/1573406416666200519085626 · Cited by 21
Low estradiol-to-testosterone ratio is associated with oligo-anovulatory cycles and atherogenic lipidic pattern in women with polycystic ovary syndrome
Amato, M. C., Verghi, M., Nucera, M., Galluzzo, A., & Giordano, C. S. D. S. (2010) · Gynecological Endocrinology · doi:10.3109/09513590.2010.495797 · Cited by 21
Hormonothérapie des cancers du sein
de Crémoux, P. (2011) · Bulletin du Cancer · doi:10.1684/bdc.2011.1466 · Cited by 20
Enolization as an Alternative Proton Delivery Pathway in Human Aromatase (P450 19A1)
Krámos, B., & Oláh, J. (2013) · The Journal of Physical Chemistry B · doi:10.1021/jp407365x · Cited by 20
Anandamide targets aromatase: A breakthrough on human decidualization
Almada, M., de Oliveira, A. L. N., Amaral, C., Fernandes, P. A., Ramos, M. J., Fonseca, B. M., Correia‐da‐Silva, G., & Teixeira, N. A. A. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2019.08.008 · Cited by 20
Placental Endocrine Function and Hormone Action
Albrecht, E. D., & Pepe, G. J. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-397175-3.00040-5 · Cited by 20
All-Atom Simulations Disclose How Cytochrome Reductase Reshapes the Substrate Access/Egress Routes of Its Partner CYP450s
Ritacco, I., Saltalamacchia, A., Spinello, A., Ippoliti, E., & Magistrato, A. (2020) · The Journal of Physical Chemistry Letters · doi:10.1021/acs.jpclett.9b03798 · Cited by 19
Diverse reactions catalyzed by cytochrome P450 and biosynthesis of steroid hormone
Fujiyama, K., Hino, T., & Nagano, S. (2022) · Biophysics and Physicobiology · doi:10.2142/biophysico.bppb-v19.0021 · Cited by 20
Potentiality of Oxygen-Ozonetherapy to Improve the Health of Aging People
Bocci, V. A., Zanardi, I., & Travagli, V. (2010) · Current Aging Science · doi:10.2174/1874609811003030177 · Cited by 19
Origin of aromatase inhibitory activity via proteochemometric modeling
Simeon, S., Spjuth, O., Lapins, M., Nabu, S., Anuwongcharoen, N., Prachayasittikul, V., Wikberg, J. E. S., & Nantasenamat, C. (2016) · PeerJ · doi:10.7717/peerj.1979 · Cited by 19
Bioactivity of curcumin on the cytochrome P450 enzymes of the steroidogenic pathwayPreprint
Castaño, P. R., Parween, S., & Pandey, A. V. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/669440 · Cited by 19
Structure–activity relationship (SAR) analysis of a family of steroids acutely controlling steroidogenesis
Midzak, A. S., Rammouz, G., & Papadopoulos, V. (2012) · Steroids · doi:10.1016/j.steroids.2012.08.019 · Cited by 17
Low systemic testosterone levels induce androgen maintenance in benign rat prostate tissue
Zhou, Y., Otto‐Duessel, M., He, M., Markel, S., Synold, T. W., & Jones, J. O. (2013) · Journal of Molecular Endocrinology · doi:10.1530/jme-13-0060 · Cited by 18
The impact of Catechol-O-methyl transferase knockdown on the cell proliferation of hormone-responsive cancers
Tolba, M. F., Omar, H. A., Hersi, F., Nunes, A. C. F., & Noreddin, A. M. (2019) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2019.03.007 · Cited by 18
Computer-Aided Drug Design (CADD) to De-Orphanize Marine Molecules: Finding Potential Therapeutic Agents for Neurodegenerative and Cardiovascular Diseases
Llorach-Parés, L., Nonell‐Canals, A., Àvila, C., & Sánchez-Martínez, M. (2022) · Marine Drugs · doi:10.3390/md20010053 · Cited by 18
Egonol gentiobioside and egonol gentiotrioside from Styrax perkinsiae promote the biosynthesis of estrogen by aromatase
Lu, D., Yang, L., Li, Q., Gao, X., Wang, F., & Zhang, G. (2012) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2012.07.005 · Cited by 18
Modulating testosterone pathway: a new strategy to tackle male skin aging?
Scior, T., Bernard, & Tuan, Q. (2012) · Clinical Interventions in Aging · doi:10.2147/cia.s34034 · Cited by 18
Discovery of novel aromatase inhibitors using a homogeneous time-resolved fluorescence assay
Ji, J., Lao, K., Hu, J., Pang, T., Jiang, Z., Yuan, H., Miao, J., Chen, X., Ning, S.-S., Xiang, H., et al. (2014) · Acta Pharmacologica Sinica · doi:10.1038/aps.2014.53 · Cited by 18
QSAR studies on indole-azole Analogues using DTC tools; imidazole ring is more favorable for aromatase inhibition
Begum, S., Jaswanthi, P., Lakshmi, B. V., & Bharathi, K. (2021) · Journal of the Indian Chemical Society · doi:10.1016/j.jics.2021.100016 · Cited by 17
The mechanism of human aromatase (CYP 19A1) revisited: DFT and QM/MM calculations support a compound I-mediated pathway for the aromatization process
Krámos, B., & Oláh, J. (2014) · Structural Chemistry · doi:10.1007/s11224-014-0545-9 · Cited by 17
Extra virgin olive oil potentiates the effects of aromatase inhibitors via glutathione depletion in estrogen receptor-positive human breast cancer (MCF-7) cells
Ismail, A. M., In, L. L. A., Tasyriq, M., Syamsir, D. R., Awang, K., Mustafa, A. H. O., Idris, O. F., Fadl-Elmula, I. M., & Hasima, N. (2013) · Food and Chemical Toxicology · doi:10.1016/j.fct.2013.10.024 · Cited by 17
Exploring new chemical functionalities to improve aromatase inhibition of steroids
Varela, C. L., Amaral, C., Correia‐da‐Silva, G., Costa, S. C., Carvalho, R. A., Costa, G., Alcaro, S., Teixeira, N. A. A., da Silva, E. J. T., & Roleira, F. M. F. (2016) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2016.04.056 · Cited by 17
Working at the membrane interface: Ligand‐induced changes in dynamic conformation and oligomeric structure in human aromatase
Nardo, G. D., Cimicata, G., Baravalle, R., Dell’Angelo, V., Ciaramella, A., Catucci, G., Ugliengo, P., & Gilardi, G. (2017) · Biotechnology and Applied Biochemistry · doi:10.1002/bab.1613 · Cited by 17
Effector role of cytochrome P450 reductase for androstenedione binding to human aromatase
Zhang, C., Catucci, G., Nardo, G. D., & Gilardi, G. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.07.163 · Cited by 17
Toxic environment and obesity pandemia: Is there a relationship?
Latini, G., Gallo, F., & Iughetti, L. (2010) · The Italian Journal of Pediatrics/Italian journal of pediatrics · doi:10.1186/1824-7288-36-8 · Cited by 17
Evaluation of binding and antagonism/downregulation of brilanestrant molecule in estrogen receptor-α via quantum mechanics/molecular mechanics, molecular dynamics and binding free energy calculations
Kalaiarasi, C., Saravanan, M., & Kumaradhas, P. (2019) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2019.1574605 · Cited by 17
Synthesis, evaluation of 6,8-dibromo-2-aryl-2,3-dihydroquinolin-4(1H)-ones in MCF-7 (breast cancer) cell lines and their docking studies
Bheemanapalli, L. N., Kaur, A., Arora, R., Sangeeta, Akkinepally, R. R., & Javali, N. M. (2011) · Medicinal Chemistry Research · doi:10.1007/s00044-011-9688-z · Cited by 17
Roles of Ferric Peroxide Anion Intermediates (Fe3+O2−, Compound 0) in Cytochrome P450 19A1 Steroid Aromatization and a Cytochrome P450 2B4 Secosteroid Oxidation Model
Tateishi, Y., McCarty, K. D., Martin, M. V., Yoshimoto, F. K., & Guengerich, F. P. (2024) · Angewandte Chemie International Edition · doi:10.1002/anie.202406542 · Cited by 16
Bioelectrochemistry as a tool for the study of aromatization of steroids by human aromatase
Nardo, G. D., Castrignanò, S., Sadeghi, S. J., Baravalle, R., & Gilardi, G. (2015) · Electrochemistry Communications · doi:10.1016/j.elecom.2015.01.007 · Cited by 16
Effectiveness of aromatase inhibitors in the treatment of advanced endometrial adenocarcinoma
Bogliolo, S., Gardella, B., Dominoni, M., Musacchi, V., Cassani, C., Zanellini, F., Silvestri, A. D., Gaggero, C. R., Babilonti, L., & Spinillo, A. (2015) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-015-3974-9 · Cited by 16
Synthesis, Aromatase Inhibitory, Antiproliferative and Molecular Modeling Studies of Functionally Diverse D-Ring Pregnenolone Pyrazoles
Banday, A. H., Saeed, B. A., & Al-Masoudi, N. A. (2020) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1871520620999201124213655 · Cited by 16
In vitro metabolism of exemestane by hepatic cytochrome P450s: impact of nonsynonymous polymorphisms on formation of the active metabolite 17β‐dihydroexemestane
Peterson, A., Xia, Z., Chen, G., & Lazarus, P. J. (2017) · Pharmacology Research & Perspectives · doi:10.1002/prp2.314 · Cited by 16
Discrete Fourier Transform-Based Multivariate Image Analysis: Application to Modeling of Aromatase Inhibitory Activity
Barigye, S. J., Freitas, M. P., Ausina, P., Zancan, P., Sola‐Penna, M., & Castillo‐Garit, J. A. (2018) · ACS Combinatorial Science · doi:10.1021/acscombsci.7b00155 · Cited by 16
Pharmacophore-based virtual screening, molecular docking, and molecular dynamics investigation for the identification of novel, marine aromatase inhibitors
Kotb, M. A., Abdelmawgood, I. A., & Ibrahim, I. M. (2024) · BMC Chemistry · doi:10.1186/s13065-024-01350-9 · Cited by 15
Computing Metal‐Binding Proteins for Therapeutic Benefit
Spinello, A., Borišek, J., Pavlin, M., Janoš, P., & Magistrato, A. (2021) · ChemMedChem · doi:10.1002/cmdc.202100109 · Cited by 14
19-hydroxy Steroids in the Aromatase Reaction: Review on Expression and Potential Functions
Abaffy, T., & Matsunami, H. (2021) · Journal of the Endocrine Society · doi:10.1210/jendso/bvab050 · Cited by 15
4th generation nonsteroidal aromatase inhibitors: An iterative SAR-guided design, synthesis, and biological evaluation towards picomolar dual binding inhibitors
Eissa, A. G., Barrow, D., Gee, J. M. W., Powell, L. E., Foster, P., & Simons, C. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2022.114569 · Cited by 15
Scorpion Venom Peptide Smp24 Revealed Apoptotic and Antiangiogenic Activities in Solid-Ehrlich Carcinoma Bearing Mice
Fawzy, B. S., Nafie, M. S., Ali, I. A. I., El-Baz, L. M. F., Xu, X., & Abdel-Rahman, M. A. (2023) · International Journal of Peptide Research and Therapeutics · doi:10.1007/s10989-023-10494-6 · Cited by 15

Authors: Ghosh, D., Griswold, J., Erman, M., & Pangborn, W.
Affiliations: Hauptman-Woodward Medical Research Institute (US)
Corresponding author: Ghosh, Debashis
ORCID: Ghosh, Debashis
Venue: Nature
Publisher: Springer Science and Business Media LLC
Published: 2009-01
Volume: 457
Issue: 7226
Pages: 219-223
ISSN: 0028-0836 (ISSN-L)
1476-4687
DOI: 10.1038/nature07614
PMC: PMC2820300
OpenAlex: W2055131068
Cited by: 618
References: 35
Citations by year: 2026: 36 · 2025: 36 · 2024: 34 · 2023: 36 · 2022: 33 · 2021: 29 · 2020: 38 · 2019: 31 · 2018: 40 · 2017: 24 · 2016: 36 · 2015: 37 · 2014: 36 · 2013: 41 · 2012: 37
FWCI: 26.91
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.springer.com/tdm (tdm)
Locations: Nature (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
RePEc: Research Papers in Economics (submittedVersion)
Funders: National Institute of General Medical Sciences (R01GM086893, GM59450, R21GM059450, R01GM062794, GM62794)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
Physical Sciences › Chemistry › Inorganic Chemistry › Metal-Catalyzed Oxygenation Mechanisms
Life Sciences › Biochemistry, Genetics and Molecular Biology › Structural Biology › Enzyme Structure and Function
Keywords: aromatase, human placental aromatase, cytochrome P450, estrogen synthesis, aromatase inhibitors, breast cancer, enzyme mechanism, substrate specificity, endoplasmic reticulum membrane, crystal structure, estradiol
MeSH terms: Androgens, Aromatase, Estrogens, Female, Humans, Lipid Bilayers, Models, Molecular, Placenta, Protein Binding, Protein Conformation, Substrate Specificity, Crystallography, X-Ray, Catalytic Domain

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Structural basis for androgen specificity and oestrogen synthesis in human aromatase

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks